top of page

Representatives of BCCOP, Osteoporosis Canada and MedAccess BC, have continued to advocate with the BC Ministry of Health to review PharmaCare criteria to enhance coverage of osteoporosis treatment.

BC PharmaCare has approved Romosozumab for coverage for postmenopausal women with osteoporosis with high risk of fractures via Special Authority Coverage with a Drug Coverage Decision.


Dr. Sonia Singh takes on new Fracture Liaison Services (FLS) leadership role at Osteoporosis Canada (OC). We are delighted that one of our own BC physicians will be taking on a national role to support FLS development across Canada. In her new role as the OC National FLS Implementation Lead, Dr. Singh will have several key duties:

  1. Provide leadership to continue to develop and update FLS practice and guidelines.

  2. Provide mentorship and training support for new FLS programs across Canada.

  3. Support ongoing quality improvement data collection and reporting to improve FLS.

  4. Explore capacity for Implementation Science Research in the area of FLS on a national basis.

  5. Represent OC internationally with respect to FLS within the global Fragility Fracture Network.


On October 10, 2023, an updated guideline for diagnosis and management of osteoporosis in Canada was published in the Canadian Medical Association Journal (CMAJ). Click to access the new guidelines.

bottom of page